Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Manual for 6 Hot Brilliant Beds - 2Step by step instructions to Think about Disc Rates Across Various Banks
- 3Exploring ways to reduce the impact of space junk on Earth
- 4Day to day Temporary Positions That Compensate Fairly in the US
- 5Director of Swiss hospital describes the rush to treat the injured from Alpine resort bar fire
- Could it be said that you are As yet Utilizing Old Tires? at These 6 Tire Brands
- Financial plan Cordial Home Redesigns That Add Worth
- South African army arrive in crime hotspots to help tackle gangs
- Select Your Go-To Bluetooth Earphones
- Scientist turns people’s mental images into text using ‘mind-captioning’ technology
- Popular Japanese Hotel Chain Now Lets You Show Up With Just Your Passport
- Qatar LNG Ships U-Turn After Attempt to Pass Through Hormuz
- Embracing Practical Living and Ecological Protection
- Lebanese Shi’a party Amal competing, coordinating with Hezbollah, experts tell ‘Post’
